Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry of Obstructive Sleep Apnea in Hypertensive Patients in China

Official title: Screening, Diagnosis and Treatment of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in China: A Prospective National Multi-center Registry

Run by Shanghai Jiao Tong University School of Medicine · NCT05735444 · Data updated 2026-11-12

This study looks at how well people with high blood pressure and sleep apnea stick to using a CPAP machine and how it affects their health over time.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment633 (estimated)
SponsorShanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedFebruary 21, 2023
Trial IDNCT05735444 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with hypertension who have a STOP-Bang score of 3 or higher and are currently undergoing CPAP therapy.

Probably not a fit

Patients with severe hypertension, other significant respiratory diseases, or those intolerant to CPAP therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the adherence to continuous positive airway pressure (CPAP) therapy in patients with hypertension and obstructive sleep apnea syndrome (OSAS) across multiple centers in China. It will assess both short- and long-term adherence to CPAP and identify predictors that influence this adherence. Additionally, the study will explore the relationship between CPAP adherence and various health outcomes, including blood pressure control and the incidence of cardiovascular events. The research is observational and involves patients who have been diagnosed with hypertension and suspected OSAS.

Why it matters

Potential benefit: If successful, this study could improve understanding of CPAP adherence and its impact on hypertension management, potentially leading to better cardiovascular outcomes for patients.

How similar studies have gone: While there have been studies on CPAP adherence, this registry approach focusing on hypertensive patients with OSAS is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Agree to participate in the study and sign the informed consent;
2. At least 18 years old;
3. STOP-Bang questionnaire, score ≥3 points;
4. Complete polysomnography in hospital;
5. Currently on CPAP therapy.

Exclusion Criteria:

1. Clinic systolic/diastolic blood pressure ≥180/110 mmHg;
2. Previous or current treatment for OSAS without CPAP;
3. Severe respiratory diseases such as chronic obstructive pulmonary disease, or contraindications to CPAP therapy, such as pneumothorax, pulmonary bulla and new-onset stroke;
4. Sleep disorders or insomnia;
5. Intolerance of CPAP therapy;
6. Patient with cognitive dysfunction who are unable to provide informed consent;
7. Other circumstances that patients are not appropriate for the study upon the investigator's judgment.

Where it's running

  • Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Jiguang Wang, MD, PhD — Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
  • Study coordinator: Jiguang Wang, MD, PhD
  • Email: jiguangw@163.com
  • Phone: +86-21-64370045

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.